EileenOBrien:
Welcome to the #socpharm chat! mark Bard is our guest moderator tonight. say hello!
EileenOBrien:
We’ll assume your opinions are your own and do not reflect your employer #socpharm
EileenOBrien:
Are you ready @digitalhealthco: ? #socpharm
EileenOBrien:
Having a slow start to #socpharm trying to log on computer for topics but get #bluescreenofdeath !
digitalhealthco:
sorry about that #socpharm – some connectivity issues this evening – welcome
CiaranSB:
Hi everyone. Ciaran here – as always looking forward to a great hour of #socpharm
crshorizon:
Hi All – Looking forward to the conversation – Chuck #SocPharm
EileenOBrien:
@digitalhealthco: me too – tx goodness for iphones #socpharm
EileenOBrien:
@digitalhealthco: I threw out a topic – does a FB post always deserve brand response? #socpharm
digitalhealthco:
great q @EileenOBrien: – I believe this goes back to the level of customer service integration at the company and brand level #socpharm
crshorizon:
@EileenOBrien: Stats show a valid expectation for a response to a question. It’s a basic form of showing respect, right? #SocPharm
EileenOBrien:
I think if someone takes the time to ask a brand a legit question the brand should respond. Common courtesy #socpharm
digitalhealthco:
if we include corporate as a brand response and it’s a corporate FB page – sure, the company has an obligation to respond to q’s #socpharm
digitalhealthco:
100% agreed – but at this point – a public brand conversation seems a no go for most #socpharm
digitalhealthco:
we live in a world near term of …. call the #800 #socpharm
CiaranSB:
T1: IMO it’s similar to responding to a phone call complaint. Triage and if big enough issue, bigger response. #socpharm
EileenOBrien:
I think we agree it’s pretty important & from what I can tell Pharma is trying to do that (whether w/canned or unique replies) #socpharm
digitalhealthco:
another q – T2 – comments on the news this week that webmd forecasts a down year (due to pharma) and a tough yr ahead? #socpharm
digitalhealthco:
is this indicative of the space in 2012 or this company specific? #socpharm
EileenOBrien:
@digitalhealthco: are u following #socpharm? Other comments there…
CiaranSB:
T2: I think it’s space for 2012. Mergers of companies=mergers of budgets #socpharm
digitalhealthco:
i am @EileenOBrien: – but still seems slow #socpharm
EileenOBrien:
IMHO always found WebMD to be overpriced… Perhaps bubble burst? #socpharm
digitalhealthco:
@CiaranSB: please expand #socpharm
digitalhealthco:
@EileenOBrien: ok – so are we seeing a reallocation into other portals and into emerging communities? #socpharm
crshorizon:
@digitalhealthco: One source on quick search shows projected moderate growth of pharma overall at about 3%. #socpharm
EileenOBrien:
Plus FB ads now offer very targeted alternative to WebMD and you only pay when someone clicks #socpharm
digitalhealthco:
great point @EileenOBrien: – they cited “social networks” as threat – anyone else see FB taking share from traditional health? #socpharm
CiaranSB:
ie #HBA in the Philly had sponsors at Wyeth, Cephalon. Now with mergers, harder to get funds from 1 comp= 3 cos. Same w agencies #socpharm
EileenOBrien:
@digitalhealthco: possibly, $ is going into online listening, communities, FB & YouTube so probably coming from other things #socpharm
CiaranSB:
I agree RT @EileenOBrien: : @digitalhealthco: $ is going into online listening, communities, FB & YouTube so coming from other things #socpharm
digitalhealthco:
@EileenOBrien: among listening, community, fb, yt – where does this group see the most interest in 2012? #socpharm
digitalhealthco:
and if you say FB – please explain #socpharm
digitalhealthco:
where is innovation specific to FB for brands in 2012? assuming pharma response remains “call the 800#” as you browse the FB site #socpharm
crshorizon:
@digitalhealthco: Great opp for pharma in listening to learn unmet needs/lingo and YT for content – user-friendly & less risk #socpharm
digitalhealthco:
final one on this theme – if social is changing spend – is G+ in the mix in 2012? #socpharm
EileenOBrien:
I like YouTube-video is powerful medium as your previous company @manharrnresear showed! Popular globally & can turn off comments #socpharm
crshorizon:
@digitalhealthco: value of G+ is TBD #socpharm
digitalhealthco:
and given recent fda insight – is twitter relevant in 2012? #socpharm
EileenOBrien:
@digitalhealthco: gr8 question re Google+ Search colleague is very keen to get us to try to start using! #socpharm
friedah03:
Frieda Hernandez here from Siren joining #socpharm
digitalhealthco:
and … any thoughts on the recent decision (and response) to integrate G+ into search? #socpharm
EileenOBrien:
Twitter should only be relevant if your target audience is there. In most cases no. #socpharm
JacqHarper:
@EileenOBrien: BSOD on MacOS? Hold down Shift on Restart to boot in Safe mode (after #socpharm)
CiaranSB:
@digitalhealthco: nice G+ forecast @EileenOBrien: included http://t.co/vHcCi1b9 #socpharm
EileenOBrien:
For those not familiar, here’s Google news http://t.co/m6qc7KRU #socpharm
digitalhealthco:
@crshorizon: so the FB budget shift ahead is all about scale – or is it something else? #socpharm
friedah03:
RT @friedah03: : @digitalhealthco: I haven’t heard a single client mention G+. Not on their radar as far as I can tell #socpharm
digitalhealthco:
@crshorizon: q was related to comment that G+ is TBD#socpharm
digitalhealthco:
anyone want to disagree with @EileenOBrien: … is twitter relevant to pharma? ever? #socpharm
crshorizon:
@digitalhealthco: more budget allocated to what’s currently working – more reliable ROI. #socpharm
EileenOBrien:
@digitalhealthco: LOL I don’t think that’s what I tweeted exactly, but I like the way you are stirring up the pot! #socpharm
digitalhealthco:
twitter and social listening Q – seems a lot of spam within twitter specific to pharma – any data mining value? examples? #socpharm
friedah03:
digitalhealthco: Twitter is another tool for microtargeting which most pharma is not doing. We see value in #raredisease #socpharm
EileenOBrien:
And back to WebMD – there’s a finite limit to the number of sponsored cholesterol & allergy sections they can sell
#socpharm
digitalhealthco:
@EileenOBrien: – I try – seems like a calm crowd tonight #socpharm
digitalhealthco:
@friedah03: ok – so it has relevance to targeted efforts to find, engage, and drive to your programs? #socpharm
EileenOBrien:
@digitalhealthco: do u want to take the last few minutes & share upcoming plans for Digital Health Coalition? #socpharm
digitalhealthco:
@EileenOBrien: ok, so we’re not finding new people for awareness – does that mean portals must reinvent with #socpharm – can they?
digitalhealthco:
@EileenOBrien: sure – thanks #socpharm
friedah03:
Correct. #Raredisease patients use hashtags too.#socpharm
digitalhealthco:
as always, http://t.co/jC9F8B6c to learn more and request info #socpharm
digitalhealthco:
for DHC members (and peers within firms) we are hosting an event Feb 6 in NYC from 2-5pm – Social Guiding Principles Summit #socpharm
EileenOBrien:
@digitalhealthco: that’s a great question, I’m going to raise again at another chat! #socpharm
digitalhealthco:
we have a short list of principles we have been refining with our 70+ member organizations #socpharm
digitalhealthco:
we plan to discuss and outline plans for 2012 – hear from thought leaders including sanofi, gilead, facebook, palio and others #socpharm
EileenOBrien:
@digitalhealthco: looking forward to meeting other DHC members & talking on Feb 6 #socpharm
friedah03:
@digitalhealthco: Sounds like a great line-up. #socpharm
digitalhealthco:
@EileenOBrien: and we look forward to seeing you there – a key goal is to continue to build consensus on the core issues for social #socpharm
EileenOBrien:
Big thanks @digitalhealthco: (Mark Bard) for moderating tonight. Next week @PhilBaumann will be posing the questions at #socpharm
digitalhealthco:
@friedah03: thanks – we need more information sharing in this industry #socpharm
digitalhealthco:
well thanks everyone for the engagement this evening – shout out to the siren team for keeping it going #socpharm
CalBjr:
RT @digitalhealthco: : @friedah03: thanks – we need more information sharing in this industry #socpharm
crshorizon:
Nice chatting – Thanks #socpharm
friedah03:
@digitalhealthco: Thank you for some very thought-provoking questions and thanks to @EileenOBrien: too #socpharm
PhilBaumann:
@EileenOBrien: Look forward to the party
#socpharm


Transcript from last #socpharm chat w/Mark Bard @digitalhealthco moderating: http://t.co/VXDZo6xM. @philbaumann will ask questions this Wed
Transcript from last #socpharm chat w/Mark Bard @digitalhealthco moderating: http://t.co/VXDZo6xM. @philbaumann will ask questions this Wed
RT @EileenOBrien: Transcript from last #socpharm chat w/Mark Bard @digitalhealthco moderating: http://t.co/faAjOfhh.